|
?:abstract
|
-
Faculty of Radiation Oncology 2018 workforce census: the status of the radiation oncology workforce in New Zealand Melissa L James, Philip Munro, John Leung, Siddhartha Baxi Radiation oncologists treat cancer with radiation treatment, which is an important cancer treatment used for up to 50% of cancer patients Change in health profile of refugees resettling in New Zealand, 1980-2014 Martin Reeve New Zealand has been officially taking refugees from overseas since the end of the Second World War Since 1980, they have all stayed at the Mangere Refugee Resettlement Centre on arrival, where they prepare of their new life in New Zealand, which has included health screening Consensus statement on the treatment of transplant-eligible patients with newly diagnosed multiple myeloma in New Zealand Nicole Chien, Ken Romeril, Bart Baker, Hugh Goodman, Henry Chan, on behalf of the Myeloma Interest Group Multiple myeloma is the second most common blood cancer in New Zealand
-
[ ]the lack of funding for oral rehabilitation including complex restorative, orthodontic treatment and oral surgery could result in a significant financial burden for long-term childhood cancer survivors and their families [ ]inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand New Zealand may finally get funded access to diabetes drugs which reduce cardiovascular events and progression of kidney disease: an audit of proposed PHARMAC criteria compared with international guidelines Moritz Vitz, Bridget Moss, Hannah Ward, Poonam Soma, Jacob Isichei-Kizito, Rosemary Hall, Jeremy Krebs Two new classes of medication for the management of type 2 diabetes, the Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitors and Glucagon-like Peptide-1 (GLP-1) Agonists are medications shown to reduce cardiovascular events and slow decline in kidney function in people with type 2 diabetes [ ]we urge the policy makers to re-evaluate this aspect and assure that every Kiwi man has the best possible understanding and access to prostate cancer screening in the future
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}